NCT06034990 ICU Fluid Utilization Survey in Southeast Asia
| NCT ID | NCT06034990 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chulalongkorn University |
| Condition | Critical Illness |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-01-31 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-01-31 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to examine the use of different types of fluids for resuscitation in different phases of fluid management in 3 types of critically ill patients including (1) not bleeding, not septic but need volume resuscitation (representing normal condition), (2) bleeding but not septic (representing normal vascular integrity but with a loss of intravascular colloids), (3) septic (representing the condition with increase vascular permeability and endothelium damage) in the ICU within Southeast Asia. The data are collected by a 10-min online survey administered to included physicians which will be distributed via multiple online channels through representatives of each countries.
Eligibility Criteria
Inclusion Criteria: 1. Specialty must be in Anesthesiology, Surgery, Critical Care Medicine, Pulmonology, Nephrology, Internal Medicine, General Practitioner 2. Practice must be in Southeast Asia hospitals 3. Must work in Surgical ICU, Medical ICU , and/or Mixed ICU Exclusion Criteria: 1.Physicians who worked in cardiac, neurology or pediatric ICUs
Contact & Investigator
Nattachai Srisawat, MD
PRINCIPAL INVESTIGATOR
Chulalongkorn University
Frequently Asked Questions
Who can join the NCT06034990 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06034990 currently recruiting?
Yes, NCT06034990 is actively recruiting participants. Contact the research team at naphtmaryx@gmail.com for enrollment information.
Where is the NCT06034990 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT06034990 clinical trial?
NCT06034990 is sponsored by Chulalongkorn University. The principal investigator is Nattachai Srisawat, MD at Chulalongkorn University. The trial plans to enroll 1,000 participants.